1995•JAMARequires access

Antibiotic Treatment for Exacerbations of Chronic Obstructive Pulmonary Disease

Edward A. Gilkey

Open publisher page 0 citations

Abstract

To the Editor. —Dr Saint and colleagues1have written an article in support of treating exacerbations of chronic obstructive pulmonary disease (COPD) with antibiotics. It is always nice to know one's applied standard of care is supported by the medical literature. Critical analysis revealed an exhaustive project leading to a conclusion with severe limitations. The selection criteria produced nine of 239 studies for metaanalysis. Randomized studies comparing treatment groups (antibiotics) vs control groups (placebo) were analyzed. A variety of outcomes were compared and averaged. In essence, averaged apples were compared with averaged oranges. No range of outcomes results were defined. For comparison between studies of effect size to be useful, the outcomes of a given study all must fall within a narrow range, with the mean defined as a representative sample of the population of outcomes studied. Even then, the mean of the means is suspect when the result

About this research paper

What this paper is about

To the Editor. —Dr Saint and colleagues1have written an article in support of treating exacerbations of chronic obstructive pulmonary disease (COPD) with antibiotics. It is always nice to know one's applied standard of care is supported by the medical literature. Critical analysis revealed an exhaustive project leading to a conclusion with severe limitations. The selection criteria produced nine of 239 studies for metaanalysis. Randomized studies comparing treatment groups (antibiotics) vs control groups (placebo) were analyzed. A variety of outcomes were compared and averaged. In essence, averaged apples were compared with averaged oranges. No range of outcomes results were defined. For comparison between studies of effect size to be useful, the outcomes of a given study all must fall within a narrow range, with the mean defined as a representative sample of the population of outcomes studied. Even then, the mean of the means is suspect when the result

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To the Editor. —Dr Saint and colleagues1have written an article in support of treating exacerbations of chronic obstructive pulmonary disease (COPD) with antibiotics. It is always nice to know one's applied standard of care is supported by the medical literature. Critical analysis revealed an exhaustive project leading to a conclusion with severe limitations. The selection criteria produced nine of 239 studies for metaanalysis. Randomized studies comparing treatment groups (antibiotics) vs control groups (placebo) were analyzed. A variety of outcomes were compared and averaged. In essence, averaged apples were compared with averaged oranges. No range of outcomes results were defined. For comparison between studies of effect size to be useful, the outcomes of a given study all must fall within a narrow range, with the mean defined as a representative sample of the population of outcomes studied. Even then, the mean of the means is suspect when the result

Key concepts: Medicine, COPD, Pulmonary disease, Placebo, Antibiotics, Intensive care medicine, Internal medicine, Population

Related papers

Back to paper searchBrowse research topicsOriginal source
Antibiotic Treatment for Exacerbations of Chronic Obstructive Pulmonary Disease — Research Paper | ScholarLens